Nabriva

Developer of pleuromutilin class of antibiotics for MDR infections

placeVienna, Vienna, Austria calendar_todayFounded 2006 groups39 employees language nabriva.com

Registered entities

Investor mix

20 investors on record; 3 have since exited.

Investor typeCountShare
Venture capital945%
Private equity525%
Bank & private debt210%
Other / undisclosed420%
Coming soon